LifeMD, Inc.
LFMD
$3.84
-$0.09-2.29%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 29.37% | 36.09% | 43.76% | 40.02% | 42.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.37% | 36.09% | 43.76% | 40.02% | 42.99% |
| Cost of Revenue | 64.61% | 54.43% | 45.77% | 27.34% | 13.52% |
| Gross Profit | 25.32% | 33.82% | 43.49% | 41.81% | 47.39% |
| SG&A Expenses | 13.53% | 21.26% | 29.91% | 35.76% | 37.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 38.78% | 35.37% | 31.82% | 45.65% | 47.04% |
| Total Operating Expenses | 19.38% | 25.45% | 32.24% | 35.90% | 36.02% |
| Operating Income | 97.42% | 85.71% | 73.60% | 7.42% | 13.41% |
| Income Before Tax | 80.05% | 74.81% | 65.90% | 10.42% | 27.24% |
| Income Tax Expenses | -48.74% | -6.07% | -6.07% | -6.07% | 83.12% |
| Earnings from Continuing Operations | 78.98% | 73.34% | 64.68% | 10.32% | 25.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -117.89% | 27.24% | 57.13% | 79.04% | 71.35% |
| Net Income | 71.71% | 69.69% | 63.93% | 19.51% | 29.85% |
| EBIT | 97.42% | 85.71% | 73.60% | 7.42% | 13.41% |
| EBITDA | 108.97% | 95.01% | 81.12% | 10.29% | 15.32% |
| EPS Basic | 66.63% | 65.66% | 62.85% | 31.37% | 40.67% |
| Normalized Basic EPS | 77.23% | 72.76% | 69.72% | 36.39% | 37.67% |
| EPS Diluted | 66.10% | 65.15% | 62.19% | 31.38% | 40.17% |
| Normalized Diluted EPS | 76.98% | 72.55% | 69.53% | 36.39% | 37.67% |
| Average Basic Shares Outstanding | 10.43% | 13.19% | 17.94% | 21.65% | 22.43% |
| Average Diluted Shares Outstanding | 11.97% | 14.81% | 19.65% | 21.65% | 22.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -2.53% | -2.30% | -1.77% | -0.24% | -0.43% |